Esperion Therapeutics
ESPR
#6818
Rank
S$0.59 B
Marketcap
$3.03
Share price
8.06%
Change (1 day)
144.59%
Change (1 year)

Esperion Therapeutics (ESPR) - Total debt

Total debt on the balance sheet as of June 2024 : S$0.35 Billion

According to Esperion Therapeutics's latest financial reports the company's total debt is S$0.35 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Esperion Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$0.35 B0.49%
2022-12-31S$0.34 B-0.55%
2021-12-31S$0.35 B43.41%
2020-12-31S$0.24 B11540.24%
2019-12-31S$2.1 M
2018-12-31N/A-100%
2017-12-31S$1.39 M-64.64%
2016-12-31S$3.95 M-34.9%
2015-12-31S$6.07 M-5.63%
2014-12-31S$6.43 M
2012-12-31S$27.84 M211.73%
2011-12-31S$8.93 M
2002-12-31S$15.25 M29.88%
2001-12-31S$11.74 M81.99%
2000-12-31S$6.45 M39.49%
1999-12-31S$4.62 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$49.76 M-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.80 B 123.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$91.23 B 25,417.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.59 B 904.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.58 B 64.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA